Alterations in AdeS and AdeR regulatory proteins in 1-(1-naphthylmethyl)-piperazine responsive colistin resistance of Acinetobacter baumannii.

Journal of Chemotherapy
Şerife YilmazGüner Söyletir

Abstract

Colistin resistant Acinetobacter baumannii strains are of great concern worldwide. However, the role of efflux pumps in colistin resistance needs to be elucidated. We investigated the changes in colistin MICs of 29 colistin resistant A. baumannii isolates in response to resistance-nodulation-division (RND)-type efflux pump inhibitor (EPI) and the alterations in AdeR and AdeS two-component regulatory proteins previously associated with the overproduction of AdeAB. The EPI, 1-(1-naphthylmethyl)-piperazine (NMP), led to significant reductions in colistin MICs. At least one of the following amino acid substitutions was found in AdeS proteins from 18 of the isolates: L172P, A94V, V27I, V32I, G186V, and G164A. Besides, A136V and V120I alterations were identified in AdeR from five isolates. Therefore, EPI-responsive colistin resistance in our isolates is most likely due to the action of an RND-type efflux system. The underlying mechanism of resistance might be the result of certain AdeRS alterations, leading to AdeAB overexpression.

References

Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J BrosiusH F Noller
Jan 1, 1969·Journal of Bacteriology·M KoikeT Matsuo
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Isabelle MarchandThierry Lambert
Mar 10, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A C GalesH S Sader
Nov 17, 2007·Nature Reviews. Microbiology·Lenie DijkshoornHarald Seifert
Dec 19, 2007·Antimicrobial Agents and Chemotherapy·Laurence Damier-PiollePatrice Courvalin
Nov 4, 2009·Antimicrobial Agents and Chemotherapy·Sébastien CoyneBruno Périchon
Jun 18, 2010·The Journal of Antimicrobial Chemotherapy·Michael HornseyNeil Woodford
Aug 11, 2010·Antimicrobial Agents and Chemotherapy·Sébastien CoyneBruno Périchon
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Jennifer H MoffattJohn D Boyce
Dec 22, 2010·Antimicrobial Agents and Chemotherapy·Sébastien CoyneBruno Périchon
Oct 4, 2011·The Journal of Antimicrobial Chemotherapy·Rémy A BonninPatrice Nordmann
Oct 15, 2011·International Journal of Antimicrobial Agents·Han-Yueh KuoMing-Li Liou
Mar 24, 2012·The Journal of Antimicrobial Chemotherapy·Yun CaiNan Bai
Oct 4, 2012·Expert Review of Anti-infective Therapy·Silpak BiswasJean-Marc Rolain
Nov 24, 2012·Proceedings of the National Academy of Sciences of the United States of America·Attilio V Vargiu, Hiroshi Nikaido
Dec 12, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Dawn M SievertUNKNOWN National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities
Aug 14, 2013·Antimicrobial Agents and Chemotherapy·C RumboUNKNOWN Spanish Network for Research in Infectious Diseases(REIPI)
Apr 8, 2014·Annual Review of Biophysics·Jared A DelmarEdward W Yu
Dec 17, 2014·Frontiers in Microbiology·Abiola O OlaitanJean-Marc Rolain
Jan 6, 2015·The Journal of Microbiology·Young Kyoung Park, Kwan Soo Ko
Aug 28, 2015·Journal of Research in Pharmacy Practice·Mandana Izadpanah, Hossein Khalili
Jan 26, 2016·Microbiological Research·Tein-Yao ChangTzong-Shi Chiueh
Mar 10, 2016·Antimicrobial Agents and Chemotherapy·Wentao NiYouning Liu
Jan 19, 2018·Journal of Clinical Microbiology·Edoardo CarrettoJonathan M Tyrrell
Apr 18, 2018·Journal of Bacteriology·Inga V LeusHelen I Zgurskaya
Jun 14, 2019·New Microbes and New Infections·S H ArdehaliL Azimi

❮ Previous
Next ❯

Citations

Apr 27, 2021·Frontiers in Microbiology·Letícia Dias de Melo CarrascoIlana Lopes Baratella da Cunha Camargo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Related Papers

Pediatria
Y CHABBERT de LAJUDIE
Antibiotica Et Chemotherapia. Fortschritte. Advances. Progrès
H SCHOENENBERG
JAMA : the Journal of the American Medical Association
W M KIRBY, C E ROBERTS
© 2021 Meta ULC. All rights reserved